Not applicableStudy completedNCT02604693
What this trial is testing
Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)
Who this might be right for
Chronic Beryllium Disease
National Jewish Health 148
Showing 6 of 6 results